• 1
    Levy B, Mukherjee T, Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet. 2000; 121: 18.
  • 2
    Cordon-Cardo C, Latres E, Drobnjak M, et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 1994; 54: 794799.
  • 3
    Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999; 154: 5360.
  • 4
    Khan J, Simon R, Bittner M, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 1998; 58: 50095013.
  • 5
    Borg I, Groenen P. Modern multidimensional scaling. Theory and applications. New York: Springer, 1997.
  • 6
    De Risi J, Penland L, Brown PO, et al. Use of microarray to analyze gene expression patterns in human cancer. Nat Genet. 1996; 14: 457460.
  • 7
    Bowtell DL. Options available –from start to finish—for obtaining expression data by microarray. Nat Genet. 1999; 21 (Suppl): 2532.
  • 8
    Taylor E, Cogdell D, Coombes K, et al. Sequence verification as quality control step for production of cDNA microarray. Biotechniques 2001; 31: 6265.
  • 9
    Baggerly KA, Coombes KR, Hess KR, Stivers DN, Abruzzo LV, Zhang W. Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol. 2001; 8: 639659.
  • 10
    Chen Y, Dougherty E, Bittner M. Ratio-based decisions and the quantitative analysis of cDNA micro-array images. J Biomed Optics 1997; 2: 364374.
  • 11
    Fukunaga K. Statistical pattern recognition. 2nd edition. San Diego: Academic Press, 1990.
  • 12
    Jin R, Bay BH, Chow VT, Tan PH, Dheen T. Significance of metallothionein expression in breast myoepithelial cells. Cell Tissue Res. 2001; 303: 221226.
  • 13
    Pannek J, Lecksell K, Partin AW. Expression of metallothionein in seminal vesicles-an immunohistochemical study. Scand J Urol Nephrol. 2001; 35: 1114.
  • 14
    Tsangaris GT, Vamvukakis J, Plitis I, Kattamis AC, Tzortzatou-Stathopoulou F. Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia. Anticancer Res. 2000; 20: 44044411.
  • 15
    Ishii K, Usui S, Yamamoto H, Sugimura Y, Tatematsu M, Hirano K. Decreases in metallothionein and aminopeptidase N in renal cancer tissues. J Biochem (Tokyo). 2001; 129: 253258.
  • 16
    Suzuki T, Matsuda S, Tsuzuku JK, Yoshida Y, Yamamoto T. A serine/threonine kinase p90rsk1 phosphorylates the antiproliferative protein Tob. Genes Cells 2001; 6: 131138.
  • 17
    Mayer TJ, Frauenhoffer EE, Meyers AC. Expression of epidermal growth factor and platelet-derived growth factor receptors during cervical carcinogenesis. In Vitro Cell Dev Biol Anim. 2000; 36: 667676.
  • 18
    Lafuente JV, Adan B, Alkiza K, Garibi JM, Rossi M, Cruz-Sanchez FF. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J Mol Neurosci. 1999; 13: 177185.